Idiopathic pulmonary arterial hypertension: current state of play and new treatment modalities

被引：5

作者：

Gibbs, JSR

Broberg, CS

Gatzoulls, MA

机构：

[1] Royal Brompton Hosp & Harefield NHS Trust, Hammersmith Hosp, London, England

[2] Univ London Imperial Coll Sci & Technol, London, England

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2004年 / 97卷

关键词：

pulmonary hypertension; prostacyclin; phosphodiesterase;

D O I：

10.1016/j.ijcard.2004.08.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Research in pulmonary hypertension has led to exciting advances over the last decade, both in terms of understanding aetiology and expanding treatment options. This review highlights the current approach to classification and disease management. In particular, we review the significant data and recommendations on the use of prostacyclin analogues, endothelin receptor antagonists, phosphodiesterase inhibitors and drug combinations. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

引用

页码：7 / 10

页数：4

共 28 条

[1] Primary pulmonary hypertension - A vascular biology and translational research "work in progress" [J].

Archer, S ;

Rich, S .

CIRCULATION, 2000, 102 (22) :2781-2791

[2] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].

Barst, RJ ;

Rubin, LJ ;

Long, WA ;

McGoon, MD ;

Rich, S ;

Badesch, DB ;

Groves, BM ;

Tapson, VF ;

Bourge, RC ;

Brundage, BH ;

Koerner, SK ;

Langleben, D ;

Keller, CA ;

Murali, S ;

Uretsky, BF ;

Clayton, LM ;

Jobsis, MM ;

Blackburn, SD ;

Shortino, D ;

Crow, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301

[3] Beraprost therapy for pulmonary arterial hypertension [J].

Barst, RJ ;

McGoon, M ;

McLaughlin, V ;

Tapson, V ;

Oudiz, R ;

Shapiro, S ;

Robbins, IM ;

Channick, R ;

Badesch, D ;

Rayburn, BK ;

Flinchbaugh, R ;

Sigman, J ;

Arneson, C ;

Jeffs, R .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2119-2125

[4] SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION WITH LONG-TERM CONTINUOUS INTRAVENOUS PROSTACYCLIN [J].

BARST, RJ ;

RUBIN, LJ ;

MCGOON, MD ;

CALDWELL, EJ ;

LONG, WA ;

LEVY, PS .

ANNALS OF INTERNAL MEDICINE, 1994, 121 (06) :409-415

[5] Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension [J].

Bustamante-Labarta, M ;

Perrone, S ;

de la Fuente, RL ;

Stutzbach, P ;

de la Hoz, RP ;

Torino, A ;

Favaloro, R .

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2002, 15 (10) :1160-1164

[6] Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study [J].

Channick, RN ;

Simonneau, G ;

Sitbon, O ;

Robbins, IM ;

Frost, A ;

Tapson, VF ;

Badesch, DB ;

Roux, S ;

Rainisio, M ;

Bodin, F ;

Rubin, LJ .

LANCET, 2001, 358 (9288) :1119-1123

[7] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY [J].

DALONZO, GE ;

BARST, RJ ;

AYRES, SM ;

BERGOFSKY, EH ;

BRUNDAGE, BH ;

DETRE, KM ;

FISHMAN, AP ;

GOLDRING, RM ;

GROVES, BM ;

KERNIS, JT ;

LEVY, PS ;

PIETRA, GG ;

REID, LM ;

REEVES, JT ;

RICH, S ;

VREIM, CE ;

WILLIAMS, GW ;

WU, M .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :343-349

[8]

Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI200112805

[9] Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension:: With pulmonary arterial hypertension:: A randomized, double-blind, placebo-controlled trial [J].

Galiè, N ;

Humbert, M ;

Vachiéry, JL ;

Vizza, CD ;

Kneussl, M ;

Manes, A ;

Sitbon, O ;

Torbicki, A ;

Delcroix, M ;

Naeije, R ;

Hoeper, M ;

Chaouat, A ;

Morand, S ;

Besse, B ;

Simonneau, G .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (09) :1496-1502

[10] Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial [J].

Ghofrani, HA ;

Wiedemann, R ;

Rose, F ;

Schermuly, RT ;

Olschewski, H ;

Weissmann, N ;

Gunther, A ;

Walmrath, D ;

Seeger, W ;

Grimminger, F .

LANCET, 2002, 360 (9337) :895-900

← 1 2 3 →